Induction of angiogenesis by lidocaine and basic fibroblast growth factor: A model for in vivo retroviral-mediated gene therapy

Journal of Surgical Research

Volumn 67, Issue 2, 1997, Pages 137-146

  Jejurikar, Sameer S ^a   Welling, Theodore H ^a   Zelenock, Jennifer A ^a   Gordon, David ^a   Burkel, William E ^a   Carlson, Bruce M ^a   Messina, Louis M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BROXURIDINE; LIDOCAINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HISTOLOGY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TARGET CELL; TRANSGENE; VASCULAR ENDOTHELIUM; VIRUS GENOME;

EID: 0031080207     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.4989     Document Type: Article

References (33)

1. 1. Harris, J., and Sikora, K. Human genetic therapy. Mol. Asp. Med. 14: 451, 1993.
2. 2. Nabel, E. G., Pompili, V. J., Plautz, G. E., and Nabel, G. J. Gene transfer and vascular disease. Cardiovasc. Res. 28: 445, 1994.
3. 3. Messina, L. M., Podrazik, R. M., Whitehill, T. A., Ekhterae, D., Brothers, T. E., Wilson, J. M., Burkel, W. E., and Stanley, J. C. Adhesion and incorporation of lac-Z-transduced endothelial cells into the intact capillary wall in the rat. Proc. Natl. Acad. Sci. USA 89: 12018, 1992.
4. 4. Messina, L. M., Welling, T. H., Sarkar, R., Shanley, C. J., and Stanley, J. C. Gene Therapy for Vascular Disease. In D. K. Andersen, S. E. Raper, L. M. Messina, and J. S. Economou (Eds.), Advances in Surgical Gene Therapy. Cedar Knolls, NJ: World Medical Press, 1994. Pp. 27-60.
5. 5. Yao, S. N., Wilson, J. M., Nabel, E. G., Kurachi, S., Hachiya, H. L., and Kurachi, K. Expression of human factor IX in rat capillary endothelial cells: Toward somatic gene therapy for hemophilia B. Proc. Natl. Acad. Sci. USA 88: 8101, 1991.
6. 6. Guyton, A. C. Overview of the circulation, and medical physics of pressure, flow, and resistance. In M. J. Wonsiewicz (Ed.), Textbook of Medical Physiology. Philadelphia: Saunders, 1991. Pp. 150-158.
7. 7. Messina, L. M., and Faulkner, J. A. The skeletal muscle. In G. B. Zelenock (Ed.), Clinical Ischemic Syndromes. St. Louis: Mosby, 1990. Pp. 457-481.
8. 8. Dolwick, M. F., Bush, F. M., and Seibel, H. R. Regeneration of masseter muscle following lidocaine-induced degeneration: A histochemical study. Acta Anat. 98: 325, 1977.
9. 9. Foster, A. H., and Carlson, B. M. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth. Analg. 59: 727, 1980.
10. 10. Carlson, B. M., and Rainin, E. A. Rat extraocular muscle regeneration: Repair of local anesthetic-induced damage. Arch. Ophthalmol. 103: 1373, 1985.
11. 11. Carlson, B. M., Shepard, B., and Komorowski, T. E. A histological study of local anesthetic-induced muscle degeneration and regeneration in the monkey. J. Orthoped. Res. 8: 485, 1990.
12. 12. Shing, Y., Folkman, J., Haudenschild, C., Lund, D., Crum, R., and Klagsbrun, M. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J. Cell. Biochem. 29: 275, 1985.
13. 13. Montesano, R., Vassalli, J-D., Baird, A., Guillemin, R., and Orci, L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83: 7297, 1986.
14. 14. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science 235: 442, 1987.
15. 15. Villaschi, S., and Nicosia, R. F. Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am. J. Pathol. 143: 181, 1993.
16. 16. Baffour, R., Berman, J., Garb, J. L., Rhee, S. W., Kaufman, J., and Friedmann, P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia. J. Vasc. Surg. 16: 181, 1992.
17. 17. Moscatelli, D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell Physiol. 131: 123, 1987.
18. 18. Vigny, M., Ollier-Hartmann, M. P., Lavigne, M., Fayein, N., Jeanny, J. C., Laurent, M., and Courtois, Y. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J. Cell Physiol. 137: 321, 1988.
19. 19. Saksela, O., Moscatelli, D., Sommer, A., and Rifkin, D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107: 743, 1988.
20. 20. Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J., and Vlodavsky, I. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28: 1737, 1989.
21. 21. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841, 1991.
22. 22. Rapraeger, A. C., Krufka, A., and Olwin, B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252: 1705, 1991.
23. 23. Bauters, C., Asahara, T., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21: 314, 1995.
24. 24. Lindner, V., Olson, N. E., Clowes, A. W., and Reidy, M. A. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest. 90: 2044, 1992.
25. 25. Hansen-Smith, F. M., Watson, L., Lu, D. Y., and Goldstein, I. Griffonia simplicifolia I: Fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle. Microvasc. Res. 36: 199, 1988.
26. 26. Muller, D. W., Gordon, D., San, H., Yang, Z., Pompili, V. J., Nabel, G. J., and Nabel, E. G. Catheter-mediated pulmonary vascular gene transfer and expression. Circ. Res. 75: 1039, 1994.
27. 27. Fields-Berry, S. C., Halliday, A. L., and Cepko, C. L. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retinal cells. Proc. Natl. Acad. Sci. USA 89: 693, 1992.
28. 28. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. Macrophages and angiogenesis. J. Leukocyte Biol. 55: 410, 1994.
29. 29. Vlodavsky, I., Folkman, J., Sullivan, R., Friedman, R., Ishai-Michaeli, R., Sasse, J., and Klagsbrun, M. Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc. Natl. Acad. Sci. USA 84: 2292, 1987.
30. 30. Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D., and Vlodavsky, I. A heparin-binding angiogenic protein -basic fibroblast growth factor - is stored within basement membrane. Am. J. Pathol. 130: 393, 1988.
31. 31. Saksela, O., and Rifkin, D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110: 767, 1990.
32. 32. Sato, Y., and Rifkin, D. B. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell. Biol. 107: 1199, 1988.
33. 33. Veomett, G., Kuszynski, C., Kazakoff, P., and Rizzino, A. Cell density regulates the number of cell surface receptors for fibroblast growth factor. Biochem. Biophys. Res. Commun. 159: 694, 1989.